Clinical
Trials


Phase 1 BPL-003 Studies in Healthy Volunteers

We are conducting a Phase 1 study of BPL-003 in healthy volunteers in London. This is a two-part, double-blind, placebo-controlled, randomised, single ascending dose study to evaluate the safety, tolerability and the pharmacokinetic and pharmacodynamic profile of intranasal BPL-003 (5-Methoxy-N,N-dimethyltryptamine Benzoate) in healthy subjects.

Study details
More about
5-MeO-DMT



Phase 1 ELE -101 Studies in Healthy Volunteers

We are conducting a Phase 1 study of ELE -101 in healthy volunteers in Manchester and Liverpool. This is a Phase I, double-blind, placebo-controlled, randomised single ascending dose study to assess the safety, tolerability, pharmacokinetic (PK) profile, pharmacodynamic (PD) and subjective drug intensity (SDI) of  intravenous (IV) doses of ELE-101 in healthy male and female adult participants.

Study details
More about
Psilocin

Investigator Initiated Studies

We are committed to understanding the therapeutic potential of psychedelic drugs and support rigorous investigator-initiated research advancing psychedelic science.

We work in collaboration with select academic institutions and researchers.

Contact us to discuss further